Routine creatine kinase testing does not provide clinical utility in the emergency department for diagnosis of acute coronary syndromes.

Routine CK testing does not provide a significant benefit to patient care and therefore represents an unnecessary system cost. Routine CK testing for the diagnosis of AMI should be eliminated from emergency departments in the era of hsTnT assays.